Drug prescriptions unadapted to the renal function in patients aged 80 years and older

REFERENCES

• Gurwitz JH, Field TS, Harrold LR, Rothschild J, DeBellis K, Seger AC, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. J Am Med Assoc. 2003;9:1107–16.
   Google Scholar
• Haramburu F, Pouyanne P, Imbs JL, Blayac JP, Begaud B. Incidence and prevalence of adverse drug reactions. Presse Med. 2000; 2:111–14.
   Google Scholar
• Lacoste-Roussillon C, Pouyanne P, Haramburu F, Miremont G, Begaud B. Incidence of serious adverse drug reactions in general practice: a prospective study. Clin Pharmacol Ther. 2001;6:458–62.
   Google Scholar
• Corsonello A, Pedone C, Corica F, Mussi C, Carbonin P, Antonelli Inc. Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients. Arch Intern Med 2005;7:790–5.
   Google Scholar
• Breton G, Froissart M, Janus N, Launay-Vacher V, Berr C, Tzourio C, et al. Inappropriate drug use and mortality in community-dwelling elderly with impaired kidney function—the three-city population-based study. Nephrol Dial Transplant 2011;9:2852–9.
   Google Scholar
• Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: Systematic review. BMC Public Health 2008;8:117.
   PubMed Web of Science ®Google Scholar
• Van Pottelbergh G, Bartholomeeusen S, Buntinx F, Degryse J. The prevalence of chronic kidney disease in a Flemish primary care morbidity register. Age Ageing 2012;2:231–3.
   Google Scholar
• Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. J Am Med Assoc. 2007;17:2038–47.
   Google Scholar
• Vaes B, Pasquet A, Wallemacq P, Rezzoug N, Mekouar H, Olivier PA, et al. The BELFRAIL (BFC80+) study: A population-based prospective cohort study of the very elderly in Belgium. BMC Geriatr. 2010;10:39.
   PubMed Web of Science ®Google Scholar
• Bartholomeeusen S, Kim CY, Mertens R, Faes C, Buntinx F. The denominator in general practice, a new approach from the Intego database. Fam Pract. 2005;4:442–7.
   Google Scholar
• Van Pottelbergh G, Vaes B, Morelle J, Jadoul M, Wallemacq P, Degryse J. Estimating GFR in the oldest old: Does it matter what equation we use? Age Ageing 2011;3:401–5.
   Google Scholar
• Levey AS, Greene T, Kusek J, Beck G. A simplified equation to predict glomerular filtration rate from serum creatinine (Abstract). J Am Soc Nephrol. 2000;11:155A.
   Google Scholar
• K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1–266.
   PubMed Web of Science ®Google Scholar
• Hassan Y, Al-Ramahi R, Abd Aziz N, Ghazali R. Drug use and dosing in chronic kidney disease. Ann Acad Med Singapore 2009;12: 1095–103.
   Google Scholar
• Stevens LA, Levey AS. Use of the MDRD study equation to estimate kidney function for drug dosing. Clin Pharmacol Ther. 2009;5:465–7.
   Google Scholar
• Hudson JQ, Nyman HA. Use of estimated glomerular filtration rate for drug dosing in the chronic kidney disease patient. Curr Opin Nephrol Hypertens 2011;5:482–91.
   Google Scholar
• Landelijke Transmurale Afspraak Chronische nierschade. Huisarts Wet 2012;52:586–97.
   Google Scholar
• Early identification and management of chronic kidney disease in adults in primary and secondary care 2010. Available at http://www.nice.org.uk/cg73 (accessed 5 June 2013).
   Google Scholar
• Van Pottelbergh G, Van Heden L, Mathei C, Degryse J. Methods to evaluate renal function in elderly patients: A systematic literature review. Age Ageing 2010;5:542–8.
   Google Scholar
• Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;1:20–9.
   Google Scholar
• Hanlon JT, Wang X, Handler SM, Weisbord S, Pugh MJ, Semla T, et al. Potentially inappropriate prescribing of primarily renally cleared medications for older veterans affairs nursing home patients. J Am Med Dir Assoc. 2011;5:377–83.
   Google Scholar
• Topinkova E, Baeyens JP, Michel JP, Lang PO. Evidence-based strategies for the optimization of pharmacotherapy in older people. Drugs Aging 2012;6:477–94.
   Google Scholar
• Merle L, Laroche ML, Dantoine T, Charmes JP. Predicting and preventing adverse drug reactions in the very old. Drugs Aging 2005;5:375–92.
   Google Scholar
• Thomsen LA, Winterstein AG, Sondergaard B, Haugbolle LS, Melander A. Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Ann Pharmacother. 2007;9:1411–26.
   Google Scholar
• Field TS, Gurwitz JH, Harrold LR, Rothschild JM, DeBellis K, Seger AC, et al. Strategies for detecting adverse drug events among older persons in the ambulatory setting. J Am Med Inform Assoc. 2004;6:492–8.
   Google Scholar